Advertisement

Topics

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

00:41 EST 15 Nov 2017 | Topix

State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China drug distribution business for $557 million, as it seeks to expand its distribution and retail network nationwide. The acquisition will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second-largest drug market.

Original Article: Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million

NEXT ARTICLE

More From BioPortfolio on "Shanghai Pharma buys U.S. Cardinal Health's China business for $557 million"

Advertisement
Quick Search
Advertisement
Advertisement